The pathological hallmarks of AD included the accumulation of β-amyloid (Aβ) plaques and tau-related neurofibrillary tangles, both of which could be quantified through advanced neuroimaging modalities and fluid-based biomarker assays [8,9,10]. This evidence concerns the gene MAPT and Alzheimer disease.